NECAP1 Gene Early infantile epileptic encephalopathy type 21 Genetic Test
Components:
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information:
Clinical History of Patient who is going for NECAP1 Gene Early infantile epileptic encephalopathy type 21 NGS Genetic DNA Test
A Genetic Counselling session to draw a pedigree chart of family members affected with NECAP1 Gene Early infantile epileptic encephalopathy type 21
Test Details:
The NECAP1 gene is associated with Early Infantile Epileptic Encephalopathy Type 21 (EIEE21), which is a rare genetic disorder characterized by seizures that begin in the first few months of life. This disorder can cause developmental delays, intellectual disability, and other neurological problems.
NGS (Next Generation Sequencing) Genetic Testing is a type of genetic testing that uses advanced technology to analyze multiple genes at once, allowing for a more comprehensive analysis of a person’s genetic makeup. This type of testing can help identify genetic mutations that may be causing a particular disorder or condition, such as EIEE21 caused by mutations in the NECAP1 gene.
NGS genetic testing for the NECAP1 gene can help diagnose EIEE21 in infants and young children who are experiencing seizures and other symptoms associated with the disorder. Early diagnosis can help parents and healthcare providers develop a treatment plan that may improve outcomes for affected children.
Test Name | NECAP1 Gene Early infantile epileptic encephalopathy type 21 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for NECAP1 Gene Early infantile epileptic encephalopathy type 21 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with NECAP1 Gene Early infantile epileptic encephalopathy type 21 |
Test Details | The NECAP1 gene is associated with Early Infantile Epileptic Encephalopathy Type 21 (EIEE21), which is a rare genetic disorder characterized by seizures that begin in the first few months of life. This disorder can cause developmental delays, intellectual disability, and other neurological problems. NGS (Next Generation Sequencing) Genetic Testing is a type of genetic testing that uses advanced technology to analyze multiple genes at once, allowing for a more comprehensive analysis of a person’s genetic makeup. This type of testing can help identify genetic mutations that may be causing a particular disorder or condition, such as EIEE21 caused by mutations in the NECAP1 gene. NGS genetic testing for the NECAP1 gene can help diagnose EIEE21 in infants and young children who are experiencing seizures and other symptoms associated with the disorder. Early diagnosis can help parents and healthcare providers develop a treatment plan that may improve outcomes for affected children. |